Latest Surgical oncology Stories
Keyhole Cup is the first medical device specifically designed for laparoscopic surgery access NEW YORK, April 24, 2013 /PRNewswire/ -- Life Care Medical Devices Ltd (OTCBB: LCMD) today announced the issuance in August 2012 of CE mark for its Keyhole Cup Laparoscopic Access Device. Keyhole Cup addresses a critical need in the laparoscopic surgery market (one of the largest medical procedure markets) and was developed to advance the standard of care for laparoscopic access. The...
AUSTIN, Texas, April 24, 2013 /PRNewswire/ -- The Texas Institute for Robotic Surgery at St. David's North Austin Medical Center recently became one of the first facilities in the nation to perform a hysterectomy using a new single-site platform for robotic surgery. "This single-site robotic platform provides surgeons with the increased dexterity, control and high-definition 3-D vision found with traditional robotic surgery, as well as the added benefit of performing the operation...
Group Purchasing Agreement Optimizes Invuity's Sales Force to Support Rapid Multi-Specialty Adoption of Eigr(TM) Illumination Technology SAN FRANCISCO, April 18, 2013 /PRNewswire/ -- Invuity®, a leading developer of advanced visualization devices to optimize minimal access and minimally invasive surgeries, has entered into a three year agreement with leading health care supply chain and contracting company Novation for Invuity's complete product portfolio. Under the terms of the...
Names Paul LaViolette as Executive Chairman and Renny Clark as Chief Financial Officer MARLBOROUGH, Mass., April 16, 2013 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announced today that it has expanded its management team. Paul LaViolette, previously Chairman of the Board, has been named Executive Chairman and Renny Clark has been named Chief Financial Officer and Treasurer. They will work...
NAPERVILLE, Ill., April 15, 2013 /PRNewswire/ -- George Salti, MD, FACS, renowned surgical oncologist and Associate Professor of Surgery at the University of Illinois at Chicago, has joined the Edward Cancer Center. Dr. Salti will serve as the Co-Medical Director of the Edward Cancer Center and Medical Director of the Edward Hospital Surgical Oncology Program. Dr. Salti uses advanced surgical techniques to treat melanoma, sarcoma, breast cancer, gastrointestinal and esophageal...
First-of-its-kind research presented today showed microwave ablation (MWA) therapy cut pain in half for patients with painful bone and soft-tissue tumors and took less time to complete than radiofrequency ablation. Pain relief lasted over 4 months on average and up to 15 months in some patients, according to results reported at the 29th Annual Meeting of the American Academy of Pain Medicine. Approximately 10,600 new cases of soft-tissue sarcoma and 2,570 new cases of bone sarcoma were...
Presentations Review Findings from Nearly 1,000 Clinical Cases Performed in Germany to Date MARLBOROUGH, Mass., April 10, 2013 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announced today that cardiologists throughout Germany gathered to discuss clinical experiences with the HeartLight System and its role in the treatment of advanced AF. The featured event was held on April 3, in conjunction...
For Some Patients INTRABEAM Could be a One-Shot Alternative to Six Weeks of Radiation after Lumpectomy WASHINGTON, April 10, 2013 /PRNewswire-USNewswire/ -- For the first time, breast cancer patients in the Washington, DC area have an opportunity to skip the traditional six weeks of radiation after breast cancer surgery and get just one dose in the operating room immediately after having their cancer removed. Making this possible is INTRABEAM Intraoperative Radiotherapy (IORT) a...
According to a new market report published by Transparency Market Research "Radiofrequency Ablation Devices Market for Pain Management- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global radiofrequency ablation devices market for pain management was valued at USD 296.6 million in 2011, and is expected to grow at a CAGR of 19.4% from 2012 to 2018, to reach an estimated value of USD 1,027.6 million in 2018. Browse the full report at...
Company Announces First Installation with Additional Sites Expected by the End of the Second Quarter BOSTON, March 19, 2013 /PRNewswire/ -- Dune Medical Devices, Inc. announced today the MarginProbe System, a breakthrough intra-operative tissue assessment device used during lumpectomy surgery to treat early-stage breast cancer, is now available to patients in the United States, with the installation of the first System at University of California, Irvine Medical Center. Dune Medical...
